Pooya Davoodi p.davoodi@keele.ac.uk
Double-Walled Microparticles-Embedded Self-Cross-Linked, Injectable, and Antibacterial Hydrogel for Controlled and Sustained Release of Chemotherapeutic Agents
Davoodi, Pooya; Ng, Wei Cheng; Yan, Wei Cheng; Srinivasan, Madapusi P.; Wang, Chi-Hwa
Authors
Wei Cheng Ng
Wei Cheng Yan
Madapusi P. Srinivasan
Chi-Hwa Wang
Abstract
First-line cancer chemotherapy has been prescribed for patients suffered from cancers for many years. However, conventional chemotherapy provides a high parenteral dosage of anticancer drugs over a short period, which may cause serious toxicities and detrimental side effects in healthy tissues. This study aims to develop a new drug delivery system (DDS) composed of double-walled microparticles and an injectable hydrogel for localized dual-agent drug delivery to tumors. The uniform double-walled microparticles loaded with cisplatin (Cis-DDP) and paclitaxel (PTX) were fabricated via coaxial electrohydrodynamic atomization (CEHDA) technique and subsequently were embedded into injectable alginate-branched polyethylenimine. The findings show the uniqueness of CEHDA technique for simply swapping the place of drugs to achieve a parallel or a sequential release profile. This study also presents the simulation of CEHDA technique using computational fluid dynamics (CFD) that will help in the optimization of CEHDA’s operating conditions prior to large-scale production of microparticles. The new synthetic hydrogel provides an additional diffusion barrier against Cis-DDP and confines premature release of drugs. In addition, the hydrogel can provide a versatile tool for retaining particles in the tumor resected cavity during the injection after debulking surgery and preventing surgical site infection due to its inherent antibacterial properties. Three-dimensional MDA-MB-231 (breast cancer) spheroid studies demonstrate a superior efficacy and a greater reduction in spheroid growth for drugs released from the proposed composite formulation over a prolonged period, as compared with free drug treatment. Overall, the new core–shell microparticles embedded into injectable hydrogel can serve as a flexible controlled release platform for modulating the release profiles of anticancer drugs and subsequently providing a superior anticancer response.
Citation
Davoodi, P., Ng, W. C., Yan, W. C., Srinivasan, M. P., & Wang, C. (2016). Double-Walled Microparticles-Embedded Self-Cross-Linked, Injectable, and Antibacterial Hydrogel for Controlled and Sustained Release of Chemotherapeutic Agents. ACS applied materials & interfaces, 8(35), 22785-22800. https://doi.org/10.1021/acsami.6b03041
Journal Article Type | Article |
---|---|
Online Publication Date | Aug 25, 2016 |
Publication Date | Sep 7, 2016 |
Deposit Date | Jun 8, 2023 |
Journal | ACS Applied Materials & Interfaces |
Print ISSN | 1944-8244 |
Electronic ISSN | 1944-8252 |
Publisher | American Chemical Society |
Peer Reviewed | Peer Reviewed |
Volume | 8 |
Issue | 35 |
Pages | 22785-22800 |
DOI | https://doi.org/10.1021/acsami.6b03041 |
Keywords | General Materials Science |
You might also like
Injectable hydrogels: An emerging therapeutic strategy for cartilage regeneration
(2023)
Journal Article
A novel injectable hydrogel-based drug delivery system for the repair of cartilage defects
(2023)
Presentation / Conference
Fabrication of an injectable hydrogel with controllable in situ pore formation for the repair of chondral lesions
(2023)
Presentation / Conference
Advanced Hydrogels for Cartilage Tissue Engineering: Recent Progress and Future Directions
(2021)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search